Home / News / Events / Events detail
Drug Discovery Chemistry, a dynamic conference for medicinal and biophysical chemists working in pharma, biotech, and academia, was held April 10-13, 2023 (PDT time) in San Diego, USA and virtually. The forum focused on the discovery and optimization challenges of small molecule drug candidates. Other topics for 2023 include targeting transcription factors, plus more expanded coverage of protein degraders, molecular glues, and artificial intelligence for early drug discovery. Yinghong Gao, Vice President of BD at Viva Biotech, Rajeev Hotchandani, Vice President of BD at Viva Biotech and Simon Bury, Head of BD & Vice President at SYNthesis med chem, attended this forum and had in-depth communication with friends and partners from the industry.
During the exhibition, Viva Biotech showcased a one-stop comprehensive service platform for drug development from early-stage structure-based drug discovery to commercial drug delivery, as well as core technologies and successful cases in protein production and preparation, structural biology, cryo-EM, drug screening, bioassay platform, chemical services, computer-aided drug design, and more. They also shared their rich R&D experience and professional insights in early drug discovery with guests, attracting the attention of many international biopharmaceutical companies.
This year, Viva Biotech will keep expanding its layout in global footprints, participate and host more international industry conferences and events, and look forward to meeting more like-minded friends to discuss new opportunities in drug discovery and development .
Copyright © Viva Biotech All Rights Reserved. 沪ICP备19036061号
- About Us
-
CRO Services
BackCRO ServicesDiscovery Biology Services
- CDMO Services
- EFS Business
- News
- Careers
- Investor Relations
- Contact Us